{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:25:05Z","timestamp":1792297505471,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2021YFC2501300"],"award-info":[{"award-number":["2021YFC2501300"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["22YF1425700"],"award-info":[{"award-number":["22YF1425700"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Aberrant coagulation and thrombosis are associated with severe COVID-19 post-SARS-CoV-2 infection, yet the underlying mechanism remains obscure. Here we show that serum levels of SARS-CoV-2 envelope (E) protein are associated with coagulation disorders of COVID-19 patients, and intravenous administration of the E protein is able to potentiate thrombosis in mice. Through protein pull-down and mass spectrometry, we find that CD36, a transmembrane glycoprotein, directly binds with E protein and mediates hyperactivation of human and mouse platelets through the p38 MAPK-NF-\u03baB signaling pathway. Conversely, the pharmacological blockade of CD36 or p38 notably attenuates human platelet activation induced by the E protein. Similarly, the genetic deficiency of\n                    <jats:italic>CD36<\/jats:italic>\n                    , as well as the pharmacological inhibition of p38 in mice, significantly diminishes E protein-induced platelet activation and thrombotic events. Together, our study reveals a critical role for the CD36-p38 axis in E protein-induced platelet hyperactivity, which could serve as an actionable target for developing therapies against aberrant thrombotic events related to the severity and mortality of COVID-19.\n                  <\/jats:p>","DOI":"10.1038\/s41467-023-40824-7","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T14:02:39Z","timestamp":1692626559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4054-3387","authenticated-orcid":false,"given":"Zihan","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3574-8807","authenticated-orcid":false,"given":"Hui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4825-5227","authenticated-orcid":false,"given":"Qiongyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junna","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfen","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuochao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9587-1180","authenticated-orcid":false,"given":"Huihui","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2510-790X","authenticated-orcid":false,"given":"Junling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7589-2264","authenticated-orcid":false,"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3720-634X","authenticated-orcid":false,"given":"Chengde","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3789-1284","authenticated-orcid":false,"given":"Saijuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6043-3340","authenticated-orcid":false,"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"40824_CR1","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708\u20131720 (2020).","journal-title":"N. Engl. J. Med."},{"key":"40824_CR2","unstructured":"WHO. WHO coronavirus disease (COVID-19) dashboard. 2022. https:\/\/covid19.who.int\/ (accessed September 17, 2022)."},{"key":"40824_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"40824_CR4","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang, N., Li, D., Wang, X. & Sun, Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 18, 844\u2013847 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"40824_CR5","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","volume":"46","author":"J Helms","year":"2020","unstructured":"Helms, J. et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 46, 1089\u20131098 (2020).","journal-title":"Intensive Care Med."},{"key":"40824_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.120.046702","volume":"142","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Deep vein thrombosis in hospitalized patients with COVID-19 in Wuhan, China: prevalence, risk factors, and outcome. Circulation 142, 114\u2013128 (2020).","journal-title":"Circulation"},{"key":"40824_CR7","doi-asserted-by":"publisher","first-page":"m1091","DOI":"10.1136\/bmj.m1091","volume":"368","author":"T Chen","year":"2020","unstructured":"Chen, T. et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368, m1091 (2020).","journal-title":"BMJ"},{"key":"40824_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","volume":"191","author":"C Lodigiani","year":"2020","unstructured":"Lodigiani, C. et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thrombosis Res. 191, 9\u201314 (2020).","journal-title":"Thrombosis Res."},{"key":"40824_CR9","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/jth.14820","volume":"18","author":"DRJ Arachchillage","year":"2020","unstructured":"Arachchillage, D. R. J. & Laffan, M. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 18, 1233\u20131234 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"40824_CR10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.7326\/M20-2566","volume":"173","author":"SF Lax","year":"2020","unstructured":"Lax, S. F. et al. Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series. Ann. Intern. Med. 173, 350\u2013361 (2020).","journal-title":"Ann. Intern. Med."},{"key":"40824_CR11","doi-asserted-by":"publisher","first-page":"E70","DOI":"10.1148\/radiol.2020203557","volume":"298","author":"YJ Suh","year":"2021","unstructured":"Suh, Y. J. et al. Pulmonary embolism and deep vein thrombosis in COVID-19: a systematic review and meta-analysis. Radiology 298, E70\u2013E80 (2021).","journal-title":"Radiology"},{"key":"40824_CR12","doi-asserted-by":"publisher","unstructured":"de Melo, G. D. et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med. 13, https:\/\/doi.org\/10.1126\/scitranslmed.abf8396 (2021).","DOI":"10.1126\/scitranslmed.abf8396"},{"key":"40824_CR13","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1080\/07853890.2022.2076901","volume":"54","author":"D Castanares-Zapatero","year":"2022","unstructured":"Castanares-Zapatero, D. et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann. Med. 54, 1473\u20131487 (2022).","journal-title":"Ann. Med."},{"key":"40824_CR14","doi-asserted-by":"publisher","first-page":"e069590","DOI":"10.1136\/bmj-2021-069590","volume":"377","author":"I Katsoularis","year":"2022","unstructured":"Katsoularis, I. et al. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study. BMJ 377, e069590 (2022).","journal-title":"BMJ"},{"key":"40824_CR15","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1016\/S2213-2600(20)30216-2","volume":"8","author":"RJ Jose","year":"2020","unstructured":"Jose, R. J. & Manuel, A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir. Med. 8, e46\u2013e47 (2020).","journal-title":"Lancet Respir. Med."},{"key":"40824_CR16","doi-asserted-by":"publisher","unstructured":"Potere, N. et al. NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis. Cardiovasc. Res. https:\/\/doi.org\/10.1093\/cvr\/cvad084 (2023).","DOI":"10.1093\/cvr\/cvad084"},{"key":"40824_CR17","doi-asserted-by":"publisher","unstructured":"Teodoro, A. G. F. et al. Inflammatory response and activation of coagulation after COVID-19 infection. Viruses 15. https:\/\/doi.org\/10.3390\/v15040938 (2023).","DOI":"10.3390\/v15040938"},{"key":"40824_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1161\/CIRCRESAHA.121.319117","volume":"129","author":"M Koupenova","year":"2021","unstructured":"Koupenova, M. et al. SARS-CoV-2 initiates programmed cell death in platelets. Circ. Res. 129, 631\u2013646 (2021).","journal-title":"Circ. Res."},{"key":"40824_CR19","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1111\/jth.15534","volume":"19","author":"TJ Barrett","year":"2021","unstructured":"Barrett, T. J. et al. Platelets contribute to disease severity in COVID-19. J. Thromb. Haemost. 19, 3139\u20133153 (2021).","journal-title":"J. Thromb. Haemost."},{"key":"40824_CR20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1182\/blood.2020007214","volume":"136","author":"BK Manne","year":"2020","unstructured":"Manne, B. K. et al. Platelet gene expression and function in patients with COVID-19. Blood 136, 1317\u20131329 (2020).","journal-title":"Blood"},{"key":"40824_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13045-020-00954-7","volume":"13","author":"S Zhang","year":"2020","unstructured":"Zhang, S. et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J. Hematol. Oncol. 13, 120 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"40824_CR22","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41422-021-00495-9","volume":"31","author":"Y Zhao","year":"2021","unstructured":"Zhao, Y. et al. SARS-CoV-2 spike protein interacts with and activates TLR41. Cell Res. 31, 818\u2013820 (2021).","journal-title":"Cell Res."},{"key":"40824_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/jth.15156","volume":"19","author":"RA Campbell","year":"2021","unstructured":"Campbell, R. A., Boilard, E. & Rondina, M. T. Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets? J. Thromb. Haemost. 19, 46\u201350 (2021).","journal-title":"J. Thromb. Haemost."},{"key":"40824_CR24","doi-asserted-by":"publisher","unstructured":"Li, T. et al. Platelets mediate inflammatory monocyte activation by SARS-CoV-2 spike protein. J Clin. Investig. 132. https:\/\/doi.org\/10.1172\/jci150101 (2022).","DOI":"10.1172\/jci150101"},{"key":"40824_CR25","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1161\/CIRCRESAHA.122.321541","volume":"132","author":"R Carnevale","year":"2023","unstructured":"Carnevale, R. et al. Toll-like receptor 4-dependent platelet-related thrombosis in SARS-CoV-2 infection. Circ. Res. 132, 290\u2013305 (2023).","journal-title":"Circ. Res."},{"key":"40824_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80464-1","volume":"11","author":"J Shilts","year":"2021","unstructured":"Shilts, J., Crozier, T. W. M., Greenwood, E. J. D., Lehner, P. J. & Wright, G. J. No evidence for basigin\/CD147 as a direct SARS-CoV-2 spike binding receptor. Sci. Rep. 11, 413 (2021).","journal-title":"Sci. Rep."},{"key":"40824_CR27","doi-asserted-by":"publisher","first-page":"200209","DOI":"10.1098\/rsob.200209","volume":"10","author":"G Duart","year":"2020","unstructured":"Duart, G. et al. SARS-CoV-2 envelope protein topology in eukaryotic membranes. Open. Biol. 10, 200209 (2020).","journal-title":"Open. Biol."},{"key":"40824_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.virusres.2015.02.023","volume":"201","author":"W Surya","year":"2015","unstructured":"Surya, W., Li, Y., Verdi\u00e0-B\u00e0guena, C., Aguilella, V. M. & Torres, J. MERS coronavirus envelope protein has a single transmembrane domain that forms pentameric ion channels. Virus Res. 201, 61\u201366 (2015).","journal-title":"Virus Res."},{"key":"40824_CR29","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41422-021-00519-4","volume":"31","author":"B Xia","year":"2021","unstructured":"Xia, B. et al. SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target. Cell Res. 31, 847\u2013860 (2021).","journal-title":"Cell Res."},{"key":"40824_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.virol.2010.01.004","volume":"399","author":"J Netland","year":"2010","unstructured":"Netland, J. et al. Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease. Virology 399, 120\u2013128 (2010).","journal-title":"Virology"},{"key":"40824_CR31","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1128\/JVI.01467-06","volume":"81","author":"ML DeDiego","year":"2007","unstructured":"DeDiego, M. L. et al. A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo. J. Virol. 81, 1701\u20131713 (2007).","journal-title":"J. Virol."},{"key":"40824_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12985-019-1182-0","volume":"16","author":"D Schoeman","year":"2019","unstructured":"Schoeman, D. & Fielding, B. C. Coronavirus envelope protein: current knowledge. Virol. J. 16, 69 (2019).","journal-title":"Virol. J."},{"key":"40824_CR33","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","volume":"22","author":"M Zheng","year":"2021","unstructured":"Zheng, M. et al. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat. Immunol. 22, 829\u2013838 (2021).","journal-title":"Nat. Immunol."},{"key":"40824_CR34","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1161\/CIRCULATIONAHA.114.010186","volume":"131","author":"L Musumeci","year":"2015","unstructured":"Musumeci, L. et al. Dual-specificity phosphatase 3 deficiency or inhibition limits platelet activation and arterial thrombosis. Circulation 131, 656\u2013668 (2015).","journal-title":"Circulation"},{"key":"40824_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ddr.21461","volume":"79","author":"A Nair","year":"2018","unstructured":"Nair, A., Morsy, M. A. & Jacob, S. Dose translation between laboratory animals and human in preclinical and clinical phases of drug development. Drug. Dev. Res. 79, 373\u2013382 (2018).","journal-title":"Drug. Dev. Res."},{"key":"40824_CR36","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718\u2013724 (2020).","journal-title":"Science"},{"key":"40824_CR37","doi-asserted-by":"publisher","unstructured":"Plan\u00e8s, R., Bert, J. B., Tairi, S., BenMohamed, L. & Bahraoui, E. SARS-CoV-2 envelope (E) protein binds and activates TLR2 pathway: a novel molecular target for COVID-19 interventions. Viruses 14. https:\/\/doi.org\/10.3390\/v14050999 (2022).","DOI":"10.3390\/v14050999"},{"key":"40824_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1161\/CIRCULATIONAHA.120.046290","volume":"143","author":"Z Qi","year":"2021","unstructured":"Qi, Z. et al. PCSK9 (Proprotein Convertase Subtilisin\/Kexin 9) enhances platelet activation, thrombosis, and myocardial infarct expansion by binding to platelet CD36. Circulation 143, 45\u201361 (2021).","journal-title":"Circulation"},{"key":"40824_CR39","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41569-018-0110-0","volume":"16","author":"PEJ van der Meijden","year":"2019","unstructured":"van der Meijden, P. E. J. & Heemskerk, J. W. M. Platelet biology and functions: new concepts and clinical perspectives. Nat. Rev. Cardiol. 16, 166\u2013179 (2019).","journal-title":"Nat. Rev. Cardiol."},{"key":"40824_CR40","doi-asserted-by":"publisher","unstructured":"Chen, Y., Zhang, J., Cui, W. & Silverstein, R. L. CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate. J. Exp. Med. 219. https:\/\/doi.org\/10.1084\/jem.20211314 (2022).","DOI":"10.1084\/jem.20211314"},{"key":"40824_CR41","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1161\/CIRCRESAHA.108.172064","volume":"102","author":"K Chen","year":"2008","unstructured":"Chen, K., Febbraio, M., Li, W. & Silverstein, R. L. A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein. Circ. Res. 102, 1512\u20131519 (2008).","journal-title":"Circ. Res."},{"key":"40824_CR42","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","volume":"21","author":"A Bonaventura","year":"2021","unstructured":"Bonaventura, A. et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat. Rev. Immunol. 21, 319\u2013329 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"40824_CR43","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1182\/blood.2020007008","volume":"136","author":"EA Middleton","year":"2020","unstructured":"Middleton, E. A. et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 136, 1169\u20131179 (2020).","journal-title":"Blood"},{"key":"40824_CR44","doi-asserted-by":"publisher","first-page":"8067857","DOI":"10.1155\/2022\/8067857","volume":"2022","author":"M Lalosevic","year":"2022","unstructured":"Lalosevic, M. et al. Alteration in redox status and lipoprotein profile in COVID-19 patients with mild, moderate, and severe pneumonia. Oxid. Med. Cell Longev. 2022, 8067857 (2022).","journal-title":"Oxid. Med. Cell Longev."},{"key":"40824_CR45","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.atherosclerosis.2022.03.033","volume":"349","author":"H Nakamura","year":"2022","unstructured":"Nakamura, H. et al. Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry. Atherosclerosis 349, 183\u2013189 (2022).","journal-title":"Atherosclerosis"},{"key":"40824_CR46","doi-asserted-by":"publisher","first-page":"2200847","DOI":"10.1080\/09537104.2023.2200847","volume":"34","author":"L Goracci","year":"2023","unstructured":"Goracci, L. et al. A platelet lipidomics signature in patients with COVID-19. Platelets 34, 2200847 (2023).","journal-title":"Platelets"},{"key":"40824_CR47","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"40824_CR48","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1182\/blood-2010-03-277236","volume":"116","author":"Z Weng","year":"2010","unstructured":"Weng, Z. et al. PTEN regulates collagen-induced platelet activation. Blood 116, 2579\u20132581 (2010).","journal-title":"Blood"},{"key":"40824_CR49","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1182\/blood-2006-01-011817","volume":"108","author":"J Liu","year":"2006","unstructured":"Liu, J., Fitzgerald, M. E., Berndt, M. C., Jackson, C. W. & Gartner, T. K. Bruton tyrosine kinase is essential for botrocetin\/VWF-induced signaling and GPIb-dependent thrombus formation in vivo. Blood 108, 2596\u20132603 (2006).","journal-title":"Blood"},{"key":"40824_CR50","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1182\/blood-2008-02-140970","volume":"112","author":"H Yin","year":"2008","unstructured":"Yin, H. et al. Src family tyrosine kinase Lyn mediates VWF\/GPIb-IX-induced platelet activation via the cGMP signaling pathway. Blood 112, 1139\u20131146 (2008).","journal-title":"Blood"},{"key":"40824_CR51","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/1873-3468.13323","volume":"593","author":"SW Ouyang","year":"2019","unstructured":"Ouyang, S. W. et al. USP10 regulates Musashi-2 stability via deubiquitination and promotes tumour proliferation in colon cancer. FEBS Lett. 593, 406\u2013413 (2019).","journal-title":"FEBS Lett."},{"key":"40824_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24315-1","volume":"12","author":"H Yin","year":"2021","unstructured":"Yin, H. et al. Extracellular matrix protein-1 secretory isoform promotes ovarian cancer through increasing alternative mRNA splicing and stemness. Nat. Commun. 12, 4230 (2021).","journal-title":"Nat. Commun."},{"key":"40824_CR53","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00432-018-2626-4","volume":"144","author":"TT Liu","year":"2018","unstructured":"Liu, T. T. et al. Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway. J. Cancer Res. Clin. Oncol. 144, 1049\u20131063 (2018).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"40824_CR54","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1084\/jem.20112322","volume":"209","author":"ML von Br\u00fchl","year":"2012","unstructured":"von Br\u00fchl, M. L. et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209, 819\u2013835 (2012).","journal-title":"J. Exp. Med."},{"key":"40824_CR55","doi-asserted-by":"publisher","first-page":"841892","DOI":"10.3389\/fnmol.2022.841892","volume":"15","author":"H Benderradji","year":"2022","unstructured":"Benderradji, H. et al. Impaired glucose homeostasis in a tau knock-in mouse model. Front. Mol. Neurosci. 15, 841892 (2022).","journal-title":"Front. Mol. Neurosci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40824-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40824-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40824-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T05:11:26Z","timestamp":1700197886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40824-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["40824"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-40824-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]},"assertion":[{"value":"3 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5077"}}